现在的位置: 首页时讯速递, 进展交流>正文
Intensive Care Medicine在线阅读
2022年03月21日 时讯速递, 进展交流 暂无评论

ONLINE FIRST (FREE ACCESS)

LATEST ARTICLES

Originals

Sepsis hospitalization and risk of subsequent cardiovascular events in adults: a population-based matched cohort study
Angriman F. et al.

OPEN ACCESS ~ Veno-venous extracorporeal membrane oxygenation (vv-ECMO) for severe respiratory failure in adult cancer patients: a retrospective multicenter analysis
Kochanek M. et al.

Factors associated with acute mesenteric ischemia among critically ill ventilated patients with shock: a post hoc analysis of the NUTRIREA2 trial
Piton G. et al.

Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19
Guidet et al.

Prophylactic melatonin for delirium in intensive care (Pro-MEDIC): a randomized controlled trial
Wibrow et al.

What's New in Intensive Care

Ten questions ICU specialists should address when managing cardiogenic acute pulmonary oedema
Aissaoui N., Hamzaoui O. and Price P.

Letter

Early neurological pupil index to predict outcome after cardiac arrest
Peluso L. et al.

VISUAL ABSTRACT

Correspondences

Prognostication model for traumatic brain injury based on age and white matter diffusion metrics in MRI brain. Author’s reply
Puybasset L., Perlbarg V. and Pelegrini-Issac M.

Time-limited trial of intensive care is more than merely life sustaining
Cheung E.H.L., Cheung J.C.H. and Yip Y.Y.

It takes two to bleed: anticoagulation intensity and the host’s vascular susceptibility
Seeliger B. et al.

Goal-directed therapy in sepsis strikes back. Author's reply
Zhang S. et al.

Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis
Yoshihiro S. and Taito S.

De-adoption of chlorhexidine oral care and ICU mortality. Authors’ reply
Dale C. and Cuthbertson B.

Death during life sustaining treatment must be considered a failure but can be acceptable if the treatment was proportional
Donaldson T.M.

Another trial for the TARGET trial
Alshaer M.H. and Peloquin C.A.

给我留言

您必须 [ 登录 ] 才能发表留言!

×
腾讯微博